An analysis of the pharmacokinetics of high dose intravenous Melphalan in multiple myeloma.

被引：0
|
作者：
Kalakonda, N [1 ]
Welby-Everard, P [1 ]
Dougal, M [1 ]
Ranson, M [1 ]
Scarffe, JH [1 ]
Chopra, R [1 ]
机构：
[1] Christie Hosp, Dept Haematol & Oncol, Manchester, Lancs, England
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4661
引用
收藏
页码：321B / 321B
页数：1
相关论文
共 50 条
  • [41] High-dose sequential chemotherapy in the treatment of multiple myeloma.
    Canales, M
    Ojeda, E
    Jiménez, V
    Jiménez, MT
    Hernández, D
    Alvárez, MT
    Martín, MP
    Bustos, JG
    Aguado, MJ
    Navarro, FH
    BONE MARROW TRANSPLANTATION, 1998, 21 : S205 - S205
  • [42] DOSE INTENSITY ANALYSIS OF MELPHALAN AND PREDNISONE IN MULTIPLE-MYELOMA
    PALMER, M
    BELCH, A
    HANSON, J
    BROX, L
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (06): : 414 - 418
  • [43] Busulphan and melphalan: A novel autograft conditioning regime in multiple myeloma.
    Clark, A
    Mitchell, L
    Alcorn, M
    Tansey, P
    Cook, G
    Franklin, IM
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 100 - 100
  • [44] Thalidomide plus melphalan in relapsed-refractory multiple myeloma.
    Offidani, M
    Mele, A
    Marconi, M
    Corvatta, L
    Candela, M
    Pieroni, S
    Malerba, L
    Rupoli, S
    Olivieri, A
    Leoni, P
    BLOOD, 2001, 98 (11) : 311B - 311B
  • [45] PHARMACOKINETICS AND PHARMACODYNAMICS OF HIGH DOSE MELPHALAN IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT.
    Cho, Y.
    Wang, J.
    Gao, Y.
    Li, J.
    Lamprecht, M.
    Jukich, M.
    Schaaf, L. J.
    Poi, M.
    Hofmeister, C. C.
    Phelps, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S38 - S38
  • [46] HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKEMIA AND MYELOMA
    MCELWAIN, TJ
    POWLES, RL
    LANCET, 1983, 2 (8354): : 822 - 824
  • [47] PHARMACOKINETICS OF MELPHALAN IN CHILDREN FOLLOWING HIGH-DOSE INTRAVENOUS-INJECTION
    TAHA, IAK
    AHMAD, RA
    ROGERS, DW
    PRITCHARD, J
    ROGERS, HJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 10 (03) : 212 - 216
  • [48] High-dose melphalan 180 mg/m2 with autologous blood stem cell transplantation for multiple myeloma.
    Dimopoulos, MA
    Papadimitriou, C
    Kostis, E
    Kouvelis, V
    Zomas, A
    Grigoraki, V
    Vervessou, E
    Sakarellou, N
    Panayiotides, P
    Anagnostopoulos, N
    BLOOD, 1999, 94 (10) : 399B - 399B
  • [49] Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma
    Popat, Rakesh
    Oakervee, Heather
    Williams, Catherine
    Cook, Mark
    Craddock, Charles
    Basu, Supratik
    Singer, Charles
    Harding, Stephen
    Foot, Nicola
    Hallam, Simon
    Odeh, Liz
    Joel, Simon
    Cavenagh, Jamie
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (06) : 887 - 894
  • [50] A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma.
    Qazilbash, Muzaffar H.
    Saliba, Rima M.
    Pelosini, Matteo
    Hosing, Chitra M.
    Mendoza, Floralyn L.
    Han, Eric
    Wang, Michael
    Weber, Donna M.
    Alousi, Amin M.
    Anderlini, Paolo
    Kebriaei, Partow
    Khouri, Issa F.
    Popat, Uday R.
    De Lima, Marcos
    Orlowski, Robert Z.
    Champlin, Richard E.
    Giralt, Sergio A.
    BLOOD, 2008, 112 (11) : 1140 - 1141
12345